Does perioperative administration of rofecoxib improve analgesia after spine, breast and orthopaedic surgery?

European Journal of Anaesthesiology

Volumn 23, Issue 3, 2006, Pages 219-226

  Riest, G ^a   Peters, J ^a   Weiss, M ^a   Pospiech, J ^a   Hoffmann, O ^a   Neuhauser M ^b   Beiderlinden, M ^a   Eikermann, M ^a,c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Biometrie und Epidemiologie   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Analgesia, intraoperative, preemptive, mulitmodal; Cyclooxygenase inhibitors, type 2, rofecoxib; Opioids, morphine; Surgery, orthopaedic, spine, breast, NSAID, non steroidae anti inflammatory drugs, side effects, efficacy

Indexed keywords

MORPHINE; ROFECOXIB;

ADULT; AGED; ARTICLE; BREAST SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PAIN ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE PAIN; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEDATION; SHIVERING; SIDE EFFECT; SPINE SURGERY; SWEATING; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BREAST; CYCLOOXYGENASE 2 INHIBITORS; DISKECTOMY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTONES; MALE; MASTECTOMY; MIDDLE AGED; MORPHINE; ORTHOPEDIC PROCEDURES; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PERIOPERATIVE CARE; SPINE; SULFONES;

EID: 33344473743     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S026502150500222X     Document Type: Article

References (42)

1. Simanski C, Neugebauer E. Postoperative pain therapy. Chirurg 2003; 74: 254-274.
2. Hopf HW, Weitz S. Postoperative pain management. Arch Surg 1994; 129: 128-132.
3. Cherny N, Ripamonti C, Pereira J et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001; 19: 2542-2554.
4. Ashburn MA, Caplan A, Carr DB et al. Practice guidelines for acute pain management in the perioperative setting. Anesthesiology 2004; 100: 1573-1581.
5. Cashman J, McAnulty G. Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use. Drugs 1995; 49: 51-70.
6. Rusy LM, Houck CS, Sullivan LJ et al. A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and bleeding. Anesth Analg 1995; 80: 226-229.
7. Moiniche S, Romsing J, Dahl JB, Tramer MR. Nonsteroidal antiinflammatory drugs and the risk of operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg 2003; 96: 68-77.
8. Reuben SS, Connelly NR. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg 2000; 91: 12221-12225.
9. Reuben SS, Bhopatkar S, Maciolek H, Joshi W, Sklar J. The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 2002; 94: 55-59.
10. Buvanendran A, Kroin JS, Tuman KJ et al. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. JAMA 2003; 290: 2411-2418.
11. Sinatra RS, Shen QJ, Halaszynski T, Luther MA, Shaheen Y. Preoperative rofecoxib oral suspension as an analgesic adjunct after lower abdominal surgery: the effects on effort-dependent pain and pulmonary function. Anesth Analg 2004; 98: 135-140.
12. Ott E, Nussmeier NA, Duke PC et al. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003; 125: 1481-1492.
13. Malan Jr TP, Marsh G, Hakki SI, Grossman E, Traylor L, Hubbard RC. Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology 2003; 98: 950-956.
14. Tang J, Li S, White PF et al. Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology 2002; 96: 1305-1309.
15. Karamanlioglu B, Turan A, Memis D, Ture M. Preoperative oral rofecoxib reduces postoperative pain and tramadol consumption in patients after abdominal hysterectomy. Anesth Analg 2004; 98: 1039-1043.
16. Koizuka S, Saito S, Obata H et al. Oral etodolac, a COX-2 inhibitor, reduces postoperative pain immediately after fast-track cardiac surgery. J Anesth 2004; 18: 9-13.
17. Reynolds LW, Hoo RK, Brill RJ, North J, Recker DP, Verburg KM. The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty. J Pain Symptom Manage 2003; 25: 133-141.
18. Barton SF, Langeland FF, Snabes MC et al. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology 2002; 97: 306-314.
19. Romsing J, Moiniche S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthesiol Scand 2004; 48: 525-546.
20. Hawkey CJ. COX-2 inhibitors. Lancet 1999; 353: 307-314.
21. Joshi W, Connelly NR, Reuben SS, Wolckenhaar M, Thakkar N. An evaluation of the safety and efficacy of administering rofecoxib for postoperative pain management. Anesth Analg 2003; 97: 35-38.
22. Huang JJ, Taguchi A, Hsu H, Andriole Jr GL, Kurz A. Preoperative oral rofecoxib does not decrease postoperative pain or morphine consumption in patients after radical prostatectomy: a prospective, randomized, double-blinded, placebo-controlled trial. J Clin Anesth 2001; 13: 94-97.
23. O'Hanlon DM, Thambipillai T, Colbert ST, Keane PW, Given HF. Timing of preemptive tenoxicam is important for postoperative analgesia. Can J Anaesth 2001; 48: 162-166.
24. Katz J. Preemptive analgesia: importance of timing. Can J Anesth 2001; 48: 105-114.
25. Steffen P, Seeling W, Reiser A, Rockemann M, Georgieff M. Differential indications for non-opioids for postoperative analgesia III. Analgesic effect of perioperative administration of metamizole plus diclofenac after spinal anesthesia. Anasthesiol Intensivmed Notfallmed Schmerzther 1997; 32: 496-501.
26. Celik JB, Tuncer S, Reisli R, Sarkilar G, Celik C, Akyurek C. A comparative study of the effect of rofecoxib (a COX-2 inhibitor) and naproxen sodium on analgesic requirements after abdominal hysterectomy. Arch Gynecol Obstet 2003; 268: 297-300.
27. Bekker A, Cooper PR, Frempong-Boadu A, Babu R, Errico T, Lebovits A. Evaluation of preoperative administration of the cyclooxygenase-2 inhibitor rofecoxib for the treatment of postoperative pain after lumbar disc surgery. Neurosurgery 2002; 50: 1053-1057.
28. Meyer R. Rofecoxib reduces perioperative morphine consumption for abdominal hysterectomy and laparoscopic gastric banding. Anaesth Intern Care 2002; 30: 389-390.
29. Romsing J, Moiniche S, Mathiesen O, Dahl JB. Reduction of opioid-related adverse events using opioid-sparing analgesia with COX-2 inhibitors lacks documentation: a systematic review. Acta Anaesthesiol Scand 2005; 49: 133-142.
30. Apfelbaum JL, Gan TJ, Zhao S, Hanna D, Chen C. Reliability and validity of the perioperative opioid-related symptom distress scale. Anesth Analg 2004; 99: 699-709.
31. Bauer P. Multiple testing in clinical trials. Statist Med 1991; 10: 871-890.
32. Breitfeld C, Peters J, Vockel T, Lorenz C, Eikermann M. Emetic effects of morphine and piritramide. Br J Anaesth 2003; 91: 218-223.
33. Casarett D, Karlawish J, Sankar P, Hirschman K, Asch DA. Designing pain research from the patient's perspective: What Trial End Points Are Important to Patients With Chronic Pain? Pain Med 2001; 2: 309-316.
34. Katz N. Reporting of clinical trials of analgesia. J Thorac Cardiovasc Surg 2003; 127: 605.
35. Oberholzer-Gee F, Inamdar NS. Merck's recall of rofecoxib - a strategic perspective. N Engl J Med 2004; 351: 2147-2149.
36. Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Donaldson III WF, Evans CH. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 1996; 21: 271-277.
37. Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Evans CH. Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 1995; 20: 2373-2378.
38. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002; 42: 553-583.
39. Gan TJ, Lubarsky DA, Flood EM et al. Patient preferences for acute pain treatment. Br J Anaesth 2004; 92: 681-688.
40. Kissin I. Preemptive analgesia. Why its effect is not always obvious. Anesthesiology 1996; 84: 1015-1019.
41. Kissin I. Preemptive analgesia. Anesthesiology 2000; 93: 1138-1143.
42. Farlow M, Potkin S, Koumaras B, Veach J, Mirski D. Analysis of outcome in retrieved dropout patients in a rivastigmine vs. placebo, 26-week, Alzheimer disease trial. Arch Neurol 2003; 60: 843-848.